Target intelligence / Profile preview

Transmembrane protein 272 (TMEM272)

Target
TMEM272
Molecular classification
Transmembrane protein, Integral component of membrane
01

Overview

Transmembrane protein 272 is a predicted integral membrane protein encoded by the human TMEM272 gene. The protein is annotated as having a transmembrane topology but its specific molecular function, biological activity, physiological role, and relevance to disease are currently unknown. It has no established association with any disease or therapeutic area, nor has it been linked to interacting drugs or biomarker applications. TMEM272 is expressed at the RNA level in several tissues according to transcriptomic databases—including brain, gastrointestinal tract, and reproductive organs—but there is no evidence for functional activity or disease relevance at this time. Early gene symbols included NCRNA00282 and LINC00282, but these have been consolidated under TMEM272. The protein is classified as “Tdark” by the Pharos resource, indicating poor characterization and lack of functional or disease annotation. If further information becomes available in future datasets, particularly with respect to function, disease role, or druggability, status as a target may change; currently, TMEM272 is not considered a therapeutic or pharmacological target.

Other names
TMEM272FLJ37307NCRNA00282LINC00282transmembrane protein 272long intergenic non-protein coding RNA 282
02

Mechanism of action

null (no drugs or mechanism data available)

03

Biological functions

Unknown (no experimental evidence for specific biological functions)
04

Disease associations

None established (not currently linked to any disease or pathological processes)
05

Safety considerations

null (no therapeutic use or safety/clinical challenge data available)
06

Interacting drugs

None reported (no drugs known to interact with TMEM272 as of the latest data)
07

Biomarkers

null (TMEM272 not used as a biomarker for any known condition or patient selection)

Beyond the preview

Go deeper on Transmembrane protein 272 (TMEM272).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 272 (TMEM272).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call